US Patent Issued to BEIJING TRICISIONBIO THERAPEUTICS on Dec. 30 for "Lipid compound and use thereof in delivery of nucleic acid" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,225, issued on Dec. 30, was assigned to BEIJING TRICISIONBIO THERAPEUTICS INC. (Beijing).

"Lipid compound and use thereof in delivery of nucleic acid" was invented by Yaoxin Lin (Beijing), Chengqiang Gao (Beijing), Shiyou Li (Beijing), Hao Wang (Beijing), Lei Wu (Beijing) and Qi Xin (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an ionizable lipid compound with an adjacent cis-double bond structure, a preparation method therefor, and the use thereof in the delivery of an active therapeutic agent (e.g., a nucleic acid). The ionizable lipid compound can provide a higher encapsulation rate of active substances and a better cell or...